RVMD
insider transactionsRevolution Medicines, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-850.8K
0 buy · 850.8K sell
Net value · 365d
-$80.2M
$0 in · $80.2M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
76
0 buy · 850.8K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
25.7K sh
Own +29%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
3.3K sh
Own +5%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
573 sh
Own +1%
-
Sell·S
Chief Operating Officer · 10b5-1
$4.7M
29.6K sh · $160.12
Own -16%
-
Exercise·M
Chief Operating Officer · 10b5-1
$681.7K
25.7K sh · $26.50
Own +16%
-
Exercise·M
Chief Operating Officer · 10b5-1
$98.4K
3.3K sh · $29.80
Own +2%
-
Exercise·M
Chief Operating Officer · 10b5-1
$23.3K
573 sh · $40.74
Own +0%
-
Sell·S
Chief Global Commercializatio…
$720.5K
4.6K sh · $156.12
Own -8%
-
Sell·S
President, Research and Devel… · 10b5-1
$651.8K
4.2K sh · $156.12
Own -1%
-
Sell·S
GOLDSMITH MARK A KEY
President and Chief Executive… · 10b5-1
$1.6M
10.0K sh · $156.12
Own -4%
-
Sell·S
General Counsel · 10b5-1
$336.7K
2.2K sh · $156.12
Own -4%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$425.0K
2.7K sh · $156.12
Own -2%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
44.9K sh
Own +149%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
15.5K sh
Own +26%
-
Sell·S
Chief Operating Officer · 10b5-1
$9.7M
60.4K sh · $160.17
Own -28%
-
Exercise·M
Chief Operating Officer · 10b5-1
$1.3M
44.9K sh · $29.80
Own +26%
-
Exercise·M
Chief Operating Officer · 10b5-1
$633.3K
15.5K sh · $40.74
Own +10%
-
Exercise·M
Chief Global Commercializatio… · 10b5-1
$0
3.1K sh
Own +3%
-
Sell·S
Chief Global Commercializatio… · 10b5-1
$65.2K
421 sh · $154.82
Own -1%
-
Sell·S
Chief Global Commercializatio… · 10b5-1
$308.1K
2.0K sh · $154.06
Own -4%
-
Sell·S
Chief Global Commercializatio… · 10b5-1
$107.3K
700 sh · $153.30
Own -1%
-
Exercise·M
Chief Global Commercializatio… · 10b5-1
$104.9K
3.1K sh · $33.62
Own +6%
-
Exercise·M
Chief Global Commercializatio… · 10b5-1
$0
3.1K sh
Own +3%
-
Sell·S
Chief Global Commercializatio… · 10b5-1
$53.7K
400 sh · $134.34
Own -1%
-
Sell·S
Chief Global Commercializatio… · 10b5-1
$139.4K
1.0K sh · $132.88
Own -2%
-
Sell·S
Chief Global Commercializatio… · 10b5-1
$220.0K
1.7K sh · $131.66
Own -3%
-
Exercise·M
Chief Global Commercializatio… · 10b5-1
$104.9K
3.1K sh · $33.62
Own +6%
-
Exercise·M
GOLDSMITH MARK A KEY
President and Chief Executive… · 10b5-1
$0
96.8K sh
Own +30%
-
Exercise·M
GOLDSMITH MARK A KEY
President and Chief Executive… · 10b5-1
$0
23.2K sh
Own +1905%
-
Sell·S
GOLDSMITH MARK A KEY
President and Chief Executive… · 10b5-1
$18.0M
120.0K sh · $150.09
Own -30%
-
Exercise·M
GOLDSMITH MARK A KEY
President and Chief Executive… · 10b5-1
$457.7K
96.8K sh · $4.73
Own +32%
-
Exercise·M
GOLDSMITH MARK A KEY
President and Chief Executive… · 10b5-1
$95.1K
23.2K sh · $4.09
Own +8%
-
Exercise·M
See Remarks · 10b5-1
$0
37.5K sh
Own +50%
-
Exercise·M
See Remarks · 10b5-1
$1.3M
37.5K sh · $33.62
Own +69%
-
Sell·S
See Remarks · 10b5-1
$167.8K
1.8K sh · $93.22
Own -2%
-
Sell·S
See Remarks · 10b5-1
$294.5K
3.1K sh · $94.16
Own -3%
-
Sell·S
See Remarks · 10b5-1
$2.0M
21.1K sh · $95.49
Own -24%
-
Sell·S
See Remarks · 10b5-1
$1.1M
11.0K sh · $96.43
Own -17%
-
Sell·S
See Remarks · 10b5-1
$38.9K
400 sh · $97.21
Own -1%
-
Sell·S
General Counsel · 10b5-1
$113.3K
1.2K sh · $97.44
Own -2%
-
Sell·S
See Remarks · 10b5-1
$200.0K
2.0K sh · $99.48
Own -2%
-
Sell·S
See Remarks · 10b5-1
$428.0K
4.3K sh · $99.48
Own -1%
-
Sell·S
See Remarks · 10b5-1
$1.3M
12.9K sh · $99.48
Own -4%
-
Sell·S
Chief Operating Officer · 10b5-1
$455.9K
4.6K sh · $99.48
Own -3%
-
Sell·S
General Counsel · 10b5-1
$178.6K
1.8K sh · $99.48
Own -3%
-
Sell·S
Chief Medical Officer · 10b5-1
$206.2K
2.1K sh · $99.48
Own -2%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$273.9K
2.8K sh · $99.48
Own -2%
-
Other·G
Director
$0
15.0K sh
Own -65%
-
Other·G
Director
$0
15.0K sh
Own -50%
-
Exercise·M
See Remarks · 10b5-1
$0
30.0K sh
Own +169%
-
Sell·S
See Remarks · 10b5-1
$87.0K
851 sh · $102.20
Own -0%
-
Exercise·M
See Remarks · 10b5-1
$122.7K
30.0K sh · $4.09
Own +10%
-
Sell·S
See Remarks · 10b5-1
$68.7K
700 sh · $98.17
Own -0%
-
Sell·S
See Remarks · 10b5-1
$349.2K
3.5K sh · $99.76
Own -1%
-
Sell·S
See Remarks · 10b5-1
$20.4K
200 sh · $102.08
Own -0%
-
Sell·S
See Remarks · 10b5-1
$213.4K
2.1K sh · $101.63
Own -3%
-
Sell·S
See Remarks · 10b5-1
$60.1K
600 sh · $100.19
Own -1%
-
Sell·S
See Remarks · 10b5-1
$9.8K
100 sh · $98.29
Own -0%
-
Sell·S
See Remarks · 10b5-1
$81.6K
800 sh · $102.00
Own -1%
-
Sell·S
See Remarks · 10b5-1
$172.5K
1.7K sh · $101.47
Own -3%
-
Sell·S
See Remarks · 10b5-1
$40.0K
400 sh · $100.12
Own -1%
-
Sell·S
See Remarks · 10b5-1
$9.8K
100 sh · $98.31
Own -0%
-
Sell·S
See Remarks · 10b5-1
$2.2M
21.3K sh · $101.60
Own -7%
-
Sell·S
See Remarks · 10b5-1
$364.6K
3.6K sh · $100.73
Own -1%
-
Grant·A
Chief Operating Officer
$0
47.6K sh
Own New
-
Grant·A
Chief Operating Officer
$0
21.1K sh
Own +15%
-
Grant·A
Chief Medical Officer
$0
34.0K sh
Own New
-
Grant·A
Chief Medical Officer
$0
15.1K sh
Own +17%
-
Grant·A
See Remarks · 10b5-1
$0
128.6K sh
Own New
-
Grant·A
See Remarks · 10b5-1
$0
57.1K sh
Own +25%
-
Grant·A
General Counsel
$0
32.5K sh
Own New
-
Grant·A
General Counsel
$0
14.5K sh
Own +31%
-
Grant·A
See Remarks
$0
47.6K sh
Own New
-
Grant·A
See Remarks
$0
21.1K sh
Own +8%
-
Grant·A
Anders Jack KEY
Chief Financial Officer
$0
45.4K sh
Own New
-
Grant·A
Anders Jack KEY
Chief Financial Officer
$0
20.2K sh
Own +19%
-
Grant·A
See Remarks
$0
34.0K sh
Own New
-
Grant·A
See Remarks
$0
15.1K sh
Own +15%
-
Exercise·M
See Remarks
$0
24.0K sh
Own +20%
-
Exercise·M
See Remarks
$13.0K
24.0K sh · $0.54
Own +10%
-
Sell·S
General Counsel · 10b5-1
$105.0K
908 sh · $115.60
Own -2%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
23.6K sh
Own +24%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
51.4K sh
Own New
-
Exercise·M
Chief Operating Officer · 10b5-1
$2.2M
51.4K sh · $42.45
Own +36%
-
Sell·S
Chief Operating Officer · 10b5-1
$174.9K
1.7K sh · $102.90
Own -1%
-
Exercise·M
Chief Operating Officer · 10b5-1
$703.1K
23.6K sh · $29.80
Own +12%
-
Sell·S
Chief Operating Officer · 10b5-1
$5.3M
53.1K sh · $100.02
Own -25%
-
Sell·S
Chief Operating Officer · 10b5-1
$2.1M
20.2K sh · $101.79
Own -12%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$0
10.0K sh
Own +169%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$424.5K
10.0K sh · $42.45
Own +9%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$980.0K
10.0K sh · $98.00
Own -8%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$239.3K
3.1K sh · $77.09
Own -3%
-
Sell·S
See Remarks · 10b5-1
$1.2M
15.4K sh · $76.82
Own -6%
-
Sell·S
General Counsel · 10b5-1
$206.5K
2.7K sh · $76.82
Own -5%
-
Sell·S
Chief Operating Officer · 10b5-1
$372.3K
4.8K sh · $76.82
Own -3%
-
Sell·S
See Remarks · 10b5-1
$418.4K
5.4K sh · $76.82
Own -2%
-
Exercise·M
See Remarks · 10b5-1
$0
60.0K sh
Own +339%
-
Sell·S
See Remarks · 10b5-1
$225.0K
3.0K sh · $75.00
Own -4%
-
Sell·S
See Remarks · 10b5-1
$225.0K
3.0K sh · $75.00
Own -4%
-
Sell·S
See Remarks · 10b5-1
$4.5M
60.0K sh · $75.08
Own -19%
-
Exercise·M
See Remarks · 10b5-1
$245.4K
60.0K sh · $4.09
Own +24%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$0
5.4K sh
Own New
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$400.9K
5.4K sh · $74.00
Own -5%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$92.1K
5.4K sh · $17.00
Own +5%
-
Exercise·M
See Remarks · 10b5-1
$0
20.0K sh
Own +17%
-
Exercise·M
See Remarks · 10b5-1
$81.8K
20.0K sh · $4.09
Own +8%
-
Sell·S
See Remarks · 10b5-1
$1.4M
20.0K sh · $70.38
Own -7%
-
Exercise·M
General Counsel · 10b5-1
$0
13.4K sh
Own New
-
Sell·S
General Counsel · 10b5-1
$939.0K
13.4K sh · $70.14
Own -21%
-
Exercise·M
General Counsel · 10b5-1
$568.3K
13.4K sh · $42.45
Own +27%
-
Other·G
See Remarks · 10b5-1
$0
50.0K sh
Own -48%
-
Other·G
See Remarks · 10b5-1
$0
50.0K sh
Own -42%
-
Other·G
See Remarks · 10b5-1
$0
50.0K sh
Own -17%
-
Other·G
See Remarks · 10b5-1
$0
50.0K sh
Own -14%
-
Exercise·M
See Remarks · 10b5-1
$0
20.0K sh
Own +15%
-
Exercise·M
See Remarks · 10b5-1
$81.8K
20.0K sh · $4.09
Own +8%
-
Sell·S
See Remarks · 10b5-1
$1.3M
20.0K sh · $65.07
Own -7%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$0
10.0K sh
Own New
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$170.0K
10.0K sh · $17.00
Own +9%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$640.0K
10.0K sh · $64.00
Own -8%
-
Exercise·M
See Remarks · 10b5-1
$0
3.5K sh
Own +2%
-
Exercise·M
See Remarks · 10b5-1
$0
26.5K sh
Own New
-
Exercise·M
See Remarks · 10b5-1
$14.4K
3.5K sh · $4.09
Own +1%
-
Exercise·M
See Remarks · 10b5-1
$29.7K
26.5K sh · $1.12
Own +8%
-
Sell·S
See Remarks · 10b5-1
$1.8M
30.0K sh · $60.31
Own -8%
-
Exercise·M
General Counsel · 10b5-1
$0
12.0K sh
Own +200%
-
Sell·S
General Counsel · 10b5-1
$660.0K
12.0K sh · $55.00
Own -19%
-
Exercise·M
General Counsel · 10b5-1
$438.8K
12.0K sh · $36.57
Own +24%
-
Exercise·M
See Remarks · 10b5-1
$0
10.0K sh
Own +61%
-
Sell·S
See Remarks · 10b5-1
$550.0K
10.0K sh · $55.00
Own -2%
-
Exercise·M
See Remarks · 10b5-1
$11.2K
10.0K sh · $1.12
Own +2%
-
Exercise·M
See Remarks · 10b5-1
$0
10.0K sh
Own +38%
-
Sell·S
See Remarks · 10b5-1
$504.7K
10.0K sh · $50.47
Own -2%
-
Exercise·M
See Remarks · 10b5-1
$11.2K
10.0K sh · $1.12
Own +2%
-
Exercise·M
See Remarks · 10b5-1
$0
25.0K sh
Own New
-
Exercise·M
See Remarks · 10b5-1
$118.2K
25.0K sh · $4.73
Own +9%
-
Sell·S
See Remarks · 10b5-1
$1.2M
25.0K sh · $48.54
Own -8%
-
Sell·S
General Counsel · 10b5-1
$79.6K
1.8K sh · $44.26
Own -3%
-
Sell·S
Chief Medical Officer · 10b5-1
$99.0K
2.2K sh · $45.82
Own -2%
-
Sell·S
See Remarks · 10b5-1
$614.5K
13.4K sh · $45.82
Own -3%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$106.3K
2.3K sh · $45.82
Own -2%
-
Sell·S
See Remarks · 10b5-1
$245.9K
5.4K sh · $45.82
Own -2%
-
Sell·S
Chief Operating Officer · 10b5-1
$218.8K
4.8K sh · $45.82
Own -3%
-
Sell·S
General Counsel · 10b5-1
$85.6K
1.9K sh · $45.82
Own -3%
-
Exercise·M
See Remarks · 10b5-1
$0
25.0K sh
Own +495%
-
Exercise·M
See Remarks · 10b5-1
$118.2K
25.0K sh · $4.73
Own +9%
-
Sell·S
See Remarks · 10b5-1
$1.1M
23.7K sh · $45.92
Own -8%
-
Sell·S
See Remarks · 10b5-1
$61.9K
1.3K sh · $46.93
Own -0%
-
Exercise·M
See Remarks · 10b5-1
$0
100.0K sh
Own New
-
Exercise·M
See Remarks · 10b5-1
$473.0K
100.0K sh · $4.73
Own +35%
-
Sell·S
See Remarks · 10b5-1
$1.9M
44.1K sh · $43.58
Own -11%
-
Sell·S
See Remarks · 10b5-1
$2.5M
55.9K sh · $44.48
Own -16%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$0
3.2K sh
Own New
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$0
2.0K sh
Own +15%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$15.1K
3.2K sh · $4.73
Own +3%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$34.8K
2.0K sh · $17.00
Own +2%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$210.4K
5.2K sh · $40.17
Own -4%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$0
2.8K sh
Own New
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$0
1.9K sh
Own +157%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$7.5K
2.8K sh · $2.68
Own +2%
-
Exercise·M
Anders Jack KEY
Chief Financial Officer · 10b5-1
$9.2K
1.9K sh · $4.73
Own +2%
-
Sell·S
Anders Jack KEY
Chief Financial Officer · 10b5-1
$190.6K
4.8K sh · $40.02
Own -4%
-
Exercise·M
See Remarks
$0
37.0K sh
Own +28%
-
Exercise·M
See Remarks
$20.0K
37.0K sh · $0.54
Own +9%
-
Grant·A
Director
$0
11.6K sh
Own New
-
Grant·A
Director
$0
3.1K sh
Own +16%
-
Grant·A
Director
$0
11.6K sh
Own New
-
Grant·A
Director
$0
3.1K sh
Own +3%
-
Grant·A
Director
$0
11.6K sh
Own New
-
Grant·A
Director
$0
3.1K sh
Own +14%
-
Grant·A
Director
$0
11.6K sh
Own New
-
Grant·A
Director
$0
3.1K sh
Own +0%
-
Grant·A
Director
$0
10.3K sh
Own New
-
Grant·A
Director
$0
2.8K sh
Own +40%
-
Grant·A
Director
$0
11.6K sh
Own New
-
Grant·A
Director
$0
3.1K sh
Own +4%
-
Grant·A
Director
$0
11.6K sh
Own New
-
Grant·A
Director
$0
3.1K sh
Own +16%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Horn Margaret A 10b5-1 | Exercise M | 25.7K | $0 |
| Jun 17, 2026 | Horn Margaret A 10b5-1 | Exercise M | 3.3K | $0 |
| Jun 17, 2026 | Horn Margaret A 10b5-1 | Exercise M | 573 | $0 |
| Jun 17, 2026 | Horn Margaret A 10b5-1 | Sell S | 29.6K | $4.7M |
| Jun 17, 2026 | Horn Margaret A 10b5-1 | Exercise M | 25.7K | $681.7K |
| Jun 17, 2026 | Horn Margaret A 10b5-1 | Exercise M | 3.3K | $98.4K |
| Jun 17, 2026 | Horn Margaret A 10b5-1 | Exercise M | 573 | $23.3K |
| Jun 16, 2026 | Mancini Anthony | Sell S | 4.6K | $720.5K |
| Jun 16, 2026 | Kelsey Stephen Michael KEY 10b5-1 | Sell S | 4.2K | $651.8K |
| Jun 16, 2026 | GOLDSMITH MARK A KEY 10b5-1 | Sell S | 10.0K | $1.6M |
| Jun 16, 2026 | Cislini Jeff 10b5-1 | Sell S | 2.2K | $336.7K |
| Jun 16, 2026 | Anders Jack KEY 10b5-1 | Sell S | 2.7K | $425.0K |
| Jun 15, 2026 | Horn Margaret A 10b5-1 | Exercise M | 44.9K | $0 |
| Jun 15, 2026 | Horn Margaret A 10b5-1 | Exercise M | 15.5K | $0 |
| Jun 15, 2026 | Horn Margaret A 10b5-1 | Sell S | 60.4K | $9.7M |
| Jun 15, 2026 | Horn Margaret A 10b5-1 | Exercise M | 44.9K | $1.3M |
| Jun 15, 2026 | Horn Margaret A 10b5-1 | Exercise M | 15.5K | $633.3K |
| May 26, 2026 | Mancini Anthony 10b5-1 | Exercise M | 3.1K | $0 |
| May 26, 2026 | Mancini Anthony 10b5-1 | Sell S | 421 | $65.2K |
| May 26, 2026 | Mancini Anthony 10b5-1 | Sell S | 2.0K | $308.1K |
| May 26, 2026 | Mancini Anthony 10b5-1 | Sell S | 700 | $107.3K |
| May 26, 2026 | Mancini Anthony 10b5-1 | Exercise M | 3.1K | $104.9K |
| Apr 27, 2026 | Mancini Anthony 10b5-1 | Exercise M | 3.1K | $0 |
| Apr 27, 2026 | Mancini Anthony 10b5-1 | Sell S | 400 | $53.7K |
| Apr 27, 2026 | Mancini Anthony 10b5-1 | Sell S | 1.0K | $139.4K |
| Apr 27, 2026 | Mancini Anthony 10b5-1 | Sell S | 1.7K | $220.0K |
| Apr 27, 2026 | Mancini Anthony 10b5-1 | Exercise M | 3.1K | $104.9K |
| Apr 15, 2026 | GOLDSMITH MARK A KEY 10b5-1 | Exercise M | 96.8K | $0 |
| Apr 15, 2026 | GOLDSMITH MARK A KEY 10b5-1 | Exercise M | 23.2K | $0 |
| Apr 15, 2026 | GOLDSMITH MARK A KEY 10b5-1 | Sell S | 120.0K | $18.0M |
| Apr 15, 2026 | GOLDSMITH MARK A KEY 10b5-1 | Exercise M | 96.8K | $457.7K |
| Apr 15, 2026 | GOLDSMITH MARK A KEY 10b5-1 | Exercise M | 23.2K | $95.1K |
| Mar 25, 2026 | Mancini Anthony 10b5-1 | Exercise M | 37.5K | $0 |
| Mar 25, 2026 | Mancini Anthony 10b5-1 | Exercise M | 37.5K | $1.3M |
| Mar 25, 2026 | Mancini Anthony 10b5-1 | Sell S | 1.8K | $167.8K |
| Mar 25, 2026 | Mancini Anthony 10b5-1 | Sell S | 3.1K | $294.5K |
| Mar 25, 2026 | Mancini Anthony 10b5-1 | Sell S | 21.1K | $2.0M |
| Mar 25, 2026 | Mancini Anthony 10b5-1 | Sell S | 11.0K | $1.1M |
| Mar 25, 2026 | Mancini Anthony 10b5-1 | Sell S | 400 | $38.9K |
| Mar 19, 2026 | Cislini Jeff 10b5-1 | Sell S | 1.2K | $113.3K |
| Mar 17, 2026 | Wang Xiaolin 10b5-1 | Sell S | 2.0K | $200.0K |
| Mar 17, 2026 | Kelsey Stephen Michael 10b5-1 | Sell S | 4.3K | $428.0K |
| Mar 17, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 12.9K | $1.3M |
| Mar 17, 2026 | Horn Margaret A 10b5-1 | Sell S | 4.6K | $455.9K |
| Mar 17, 2026 | Cislini Jeff 10b5-1 | Sell S | 1.8K | $178.6K |
| Mar 17, 2026 | Wei Lin 10b5-1 | Sell S | 2.1K | $206.2K |
| Mar 17, 2026 | Anders Jack KEY 10b5-1 | Sell S | 2.8K | $273.9K |
| Mar 4, 2026 | ANDERSON ELIZABETH M | Other G | 15.0K | $0 |
| Mar 4, 2026 | ANDERSON ELIZABETH M | Other G | 15.0K | $0 |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Exercise M | 30.0K | $0 |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 851 | $87.0K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Exercise M | 30.0K | $122.7K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 700 | $68.7K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 3.5K | $349.2K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 200 | $20.4K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 2.1K | $213.4K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 600 | $60.1K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 100 | $9.8K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 800 | $81.6K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 1.7K | $172.5K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 400 | $40.0K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 100 | $9.8K |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 21.3K | $2.2M |
| Mar 2, 2026 | GOLDSMITH MARK A 10b5-1 | Sell S | 3.6K | $364.6K |
| Mar 1, 2026 | Horn Margaret A | Grant A | 47.6K | $0 |
| Mar 1, 2026 | Horn Margaret A | Grant A | 21.1K | $0 |
| Mar 1, 2026 | Wei Lin | Grant A | 34.0K | $0 |
| Mar 1, 2026 | Wei Lin | Grant A | 15.1K | $0 |
| Mar 1, 2026 | GOLDSMITH MARK A 10b5-1 | Grant A | 128.6K | $0 |
| Mar 1, 2026 | GOLDSMITH MARK A 10b5-1 | Grant A | 57.1K | $0 |
| Mar 1, 2026 | Cislini Jeff | Grant A | 32.5K | $0 |
| Mar 1, 2026 | Cislini Jeff | Grant A | 14.5K | $0 |
| Mar 1, 2026 | Kelsey Stephen Michael | Grant A | 47.6K | $0 |
| Mar 1, 2026 | Kelsey Stephen Michael | Grant A | 21.1K | $0 |
| Mar 1, 2026 | Anders Jack KEY | Grant A | 45.4K | $0 |
| Mar 1, 2026 | Anders Jack KEY | Grant A | 20.2K | $0 |
| Mar 1, 2026 | Wang Xiaolin | Grant A | 34.0K | $0 |
| Mar 1, 2026 | Wang Xiaolin | Grant A | 15.1K | $0 |
| Feb 6, 2026 | GOLDSMITH MARK A | Exercise M | 24.0K | $0 |
| Feb 6, 2026 | GOLDSMITH MARK A | Exercise M | 24.0K | $13.0K |
| Jan 21, 2026 | Cislini Jeff 10b5-1 | Sell S | 908 | $105.0K |
| Jan 7, 2026 | Horn Margaret A 10b5-1 | Exercise M | 23.6K | $0 |
| Jan 7, 2026 | Horn Margaret A 10b5-1 | Exercise M | 51.4K | $0 |
| Jan 7, 2026 | Horn Margaret A 10b5-1 | Exercise M | 51.4K | $2.2M |
| Jan 7, 2026 | Horn Margaret A 10b5-1 | Sell S | 1.7K | $174.9K |
| Jan 7, 2026 | Horn Margaret A 10b5-1 | Exercise M | 23.6K | $703.1K |
| Jan 7, 2026 | Horn Margaret A 10b5-1 | Sell S | 53.1K | $5.3M |
| Jan 7, 2026 | Horn Margaret A 10b5-1 | Sell S | 20.2K | $2.1M |
| Jan 7, 2026 | Anders Jack KEY 10b5-1 | Exercise M | 10.0K | $0 |
| Jan 7, 2026 | Anders Jack KEY 10b5-1 | Exercise M | 10.0K | $424.5K |
| Jan 7, 2026 | Anders Jack KEY 10b5-1 | Sell S | 10.0K | $980.0K |
| Dec 16, 2025 | Anders Jack KEY 10b5-1 | Sell S | 3.1K | $239.3K |
| Dec 16, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 15.4K | $1.2M |
| Dec 16, 2025 | Cislini Jeff 10b5-1 | Sell S | 2.7K | $206.5K |
| Dec 16, 2025 | Horn Margaret A 10b5-1 | Sell S | 4.8K | $372.3K |
| Dec 16, 2025 | Kelsey Stephen Michael 10b5-1 | Sell S | 5.4K | $418.4K |
| Nov 25, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 60.0K | $0 |
| Nov 25, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 3.0K | $225.0K |
| Nov 25, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 3.0K | $225.0K |
| Nov 25, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 60.0K | $4.5M |
| Nov 25, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 60.0K | $245.4K |
| Nov 25, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 5.4K | $0 |
| Nov 25, 2025 | Anders Jack KEY 10b5-1 | Sell S | 5.4K | $400.9K |
| Nov 25, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 5.4K | $92.1K |
| Nov 18, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 20.0K | $0 |
| Nov 18, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 20.0K | $81.8K |
| Nov 18, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 20.0K | $1.4M |
| Nov 18, 2025 | Cislini Jeff 10b5-1 | Exercise M | 13.4K | $0 |
| Nov 18, 2025 | Cislini Jeff 10b5-1 | Sell S | 13.4K | $939.0K |
| Nov 18, 2025 | Cislini Jeff 10b5-1 | Exercise M | 13.4K | $568.3K |
| Nov 12, 2025 | GOLDSMITH MARK A 10b5-1 | Other G | 50.0K | $0 |
| Nov 12, 2025 | GOLDSMITH MARK A 10b5-1 | Other G | 50.0K | $0 |
| Nov 12, 2025 | GOLDSMITH MARK A 10b5-1 | Other G | 50.0K | $0 |
| Nov 12, 2025 | GOLDSMITH MARK A 10b5-1 | Other G | 50.0K | $0 |
| Nov 12, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 20.0K | $0 |
| Nov 12, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 20.0K | $81.8K |
| Nov 12, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 20.0K | $1.3M |
| Nov 11, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 10.0K | $0 |
| Nov 11, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 10.0K | $170.0K |
| Nov 11, 2025 | Anders Jack KEY 10b5-1 | Sell S | 10.0K | $640.0K |
| Nov 7, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 3.5K | $0 |
| Nov 7, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 26.5K | $0 |
| Nov 7, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 3.5K | $14.4K |
| Nov 7, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 26.5K | $29.7K |
| Nov 7, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 30.0K | $1.8M |
| Oct 17, 2025 | Cislini Jeff 10b5-1 | Exercise M | 12.0K | $0 |
| Oct 17, 2025 | Cislini Jeff 10b5-1 | Sell S | 12.0K | $660.0K |
| Oct 17, 2025 | Cislini Jeff 10b5-1 | Exercise M | 12.0K | $438.8K |
| Oct 17, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 10.0K | $0 |
| Oct 17, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 10.0K | $550.0K |
| Oct 17, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 10.0K | $11.2K |
| Oct 16, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 10.0K | $0 |
| Oct 16, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 10.0K | $504.7K |
| Oct 16, 2025 | GOLDSMITH MARK A 10b5-1 | Exercise M | 10.0K | $11.2K |
| Oct 13, 2025 | Kelsey Stephen Michael 10b5-1 | Exercise M | 25.0K | $0 |
| Oct 13, 2025 | Kelsey Stephen Michael 10b5-1 | Exercise M | 25.0K | $118.2K |
| Oct 13, 2025 | Kelsey Stephen Michael 10b5-1 | Sell S | 25.0K | $1.2M |
| Sep 24, 2025 | Cislini Jeff 10b5-1 | Sell S | 1.8K | $79.6K |
| Sep 16, 2025 | Wei Lin 10b5-1 | Sell S | 2.2K | $99.0K |
| Sep 16, 2025 | GOLDSMITH MARK A 10b5-1 | Sell S | 13.4K | $614.5K |
| Sep 16, 2025 | Anders Jack KEY 10b5-1 | Sell S | 2.3K | $106.3K |
| Sep 16, 2025 | Kelsey Stephen Michael 10b5-1 | Sell S | 5.4K | $245.9K |
| Sep 16, 2025 | Horn Margaret A 10b5-1 | Sell S | 4.8K | $218.8K |
| Sep 16, 2025 | Cislini Jeff 10b5-1 | Sell S | 1.9K | $85.6K |
| Sep 15, 2025 | Kelsey Stephen Michael 10b5-1 | Exercise M | 25.0K | $0 |
| Sep 15, 2025 | Kelsey Stephen Michael 10b5-1 | Exercise M | 25.0K | $118.2K |
| Sep 15, 2025 | Kelsey Stephen Michael 10b5-1 | Sell S | 23.7K | $1.1M |
| Sep 15, 2025 | Kelsey Stephen Michael 10b5-1 | Sell S | 1.3K | $61.9K |
| Sep 11, 2025 | Kelsey Stephen Michael 10b5-1 | Exercise M | 100.0K | $0 |
| Sep 11, 2025 | Kelsey Stephen Michael 10b5-1 | Exercise M | 100.0K | $473.0K |
| Sep 11, 2025 | Kelsey Stephen Michael 10b5-1 | Sell S | 44.1K | $1.9M |
| Sep 11, 2025 | Kelsey Stephen Michael 10b5-1 | Sell S | 55.9K | $2.5M |
| Sep 3, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 3.2K | $0 |
| Sep 3, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 2.0K | $0 |
| Sep 3, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 3.2K | $15.1K |
| Sep 3, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 2.0K | $34.8K |
| Sep 3, 2025 | Anders Jack KEY 10b5-1 | Sell S | 5.2K | $210.4K |
| Sep 2, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 2.8K | $0 |
| Sep 2, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 1.9K | $0 |
| Sep 2, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 2.8K | $7.5K |
| Sep 2, 2025 | Anders Jack KEY 10b5-1 | Exercise M | 1.9K | $9.2K |
| Sep 2, 2025 | Anders Jack KEY 10b5-1 | Sell S | 4.8K | $190.6K |
| Jun 30, 2025 | GOLDSMITH MARK A | Exercise M | 37.0K | $0 |
| Jun 30, 2025 | GOLDSMITH MARK A | Exercise M | 37.0K | $20.0K |
| Jun 26, 2025 | ANDERSON ELIZABETH M | Grant A | 11.6K | $0 |
| Jun 26, 2025 | ANDERSON ELIZABETH M | Grant A | 3.1K | $0 |
| Jun 26, 2025 | Horning Sandra | Grant A | 11.6K | $0 |
| Jun 26, 2025 | Horning Sandra | Grant A | 3.1K | $0 |
| Jun 26, 2025 | Borellini Flavia | Grant A | 11.6K | $0 |
| Jun 26, 2025 | Borellini Flavia | Grant A | 3.1K | $0 |
| Jun 26, 2025 | Borisy Alexis | Grant A | 11.6K | $0 |
| Jun 26, 2025 | Borisy Alexis | Grant A | 3.1K | $0 |
| Jun 26, 2025 | Clyburn Frank | Grant A | 10.3K | $0 |
| Jun 26, 2025 | Clyburn Frank | Grant A | 2.8K | $0 |
| Jun 26, 2025 | Kim Lorence H. | Grant A | 11.6K | $0 |
| Jun 26, 2025 | Kim Lorence H. | Grant A | 3.1K | $0 |
| Jun 26, 2025 | Patel Sushil | Grant A | 11.6K | $0 |
| Jun 26, 2025 | Patel Sushil | Grant A | 3.1K | $0 |
About RVMD insider trading
This page tracks insider transactions for Revolution Medicines, Inc. (RVMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.